Katarina Le Blanc

Research interests

Publications

• Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression

  Stem Cells · 2016 · https://doi.org/10.1002/stem.2509

• Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

  Journal of Extracellular Vesicles · 2015 · https://doi.org/10.3402/jev.v4.26316

• Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells

  Diabetes · 2014 · https://doi.org/10.2337/db14-0656

• Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?

  Stem Cells · 2014 · https://doi.org/10.1002/stem.1729

• Multipotent mesenchymal stromal cells and the innate immune system

  Nature reviews. Immunology · 2012 · https://doi.org/10.1038/nri3209

• Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?

  Stem Cells · 2012 · https://doi.org/10.1002/stem.1111

• Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation

  Stem Cells · 2012 · https://doi.org/10.1002/stem.1118

• Defining the risks of mesenchymal stromal cell therapy

  Cytotherapy · 2010 · https://doi.org/10.3109/14653249.2010.507330

• Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells

  Stem Cells · 2010 · https://doi.org/10.1002/stem.459

• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

  The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)60690-x

• No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients

  Haematologica · 2007 · https://doi.org/10.3324/haematol.11446

• Immunomodulation by mesenchymal stem cells and clinical experience

  Journal of Internal Medicine · 2007 · https://doi.org/10.1111/j.1365-2796.2007.01844.x

• Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells

  Leukemia · 2007 · https://doi.org/10.1038/sj.leu.2404777

• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  Transplantation · 2006 · https://doi.org/10.1097/01.tp.0000214462.63943.14

• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

  Cytotherapy · 2006 · https://doi.org/10.1080/14653240600855905

• Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

  Cytotherapy · 2005 · https://doi.org/10.1080/14653240500319234

• Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta

  Transplantation · 2005 · https://doi.org/10.1097/01.tp.0000159029.48678.93

• Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation

  Transplantation and Cellular Therapy · 2005 · https://doi.org/10.1016/j.bbmt.2005.01.005

• Mesenchymal stem cells: progress toward promise

  Cytotherapy · 2005 · https://doi.org/10.1016/s1465-3249(05)70787-8

• Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes

  Scandinavian Journal of Immunology · 2004 · https://doi.org/10.1111/j.0300-9475.2004.01483.x

• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

  The Lancet · 2004 · https://doi.org/10.1016/s0140-6736(04)16104-7

• HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

  Experimental Hematology · 2003 · https://doi.org/10.1016/s0301-472x(03)00110-3

• Immunomodulatory effects of fetal and adult mesenchymal stem cells

  Cytotherapy · 2003 · https://doi.org/10.1080/14653240310003611

• Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

  Scandinavian Journal of Immunology · 2003 · https://doi.org/10.1046/j.1365-3083.2003.01176.x

• Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

  Transplantation · 2003 · https://doi.org/10.1097/01.tp.0000082540.43730.80

Current projects

No projects listed.